Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

Man-Qing Cao
A-Bin You
Xiao-Dong Zhu
Wei Zhang
Yuan-Yuan Zhang
Shi-Zhe Zhang
Kei-wei Zhang
Hao Cai
Wen-Kai Shi
Xiao-Long Li
Kang-Shuai Li
Dong-Mei Gao
De-Ning Ma
Bo-Gen Ye
Cheng-Hao Wang
Cheng-Dong Qin
Hui-Chan Sun
Ti Zhang
Zhao-You Tang

April 2018

The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing Cy...

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7).

Ebert, K.
Zwingenberger, G.
Barbaria, E.
Keller, S.
Heck, C.
Arnold, R.
Hollerieth, V.
Mattes, J.
Geffers, R.
Raimundez-Alvarez, E.
Hasenauer, J.
Luber, B.

January 2020

Following publication of the original article [1], the authors reported an error in the labeling of ...

Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Xiaolan Lian
Yu-Min Lin
Shingo Kozono
Megan K. Herbert
Xin Li
Xiaohong Yuan
Jiangrui Guo
Yafei Guo
Min Tang
Jia Lin
Yiping Huang
Bixin Wang
Chenxi Qiu
Cheng-Yu Tsai
Jane Xie
Ziang Jeff Gao
Yong Wu
Hekun Liu
Xiao Zhen Zhou
Kun Ping Lu
Yuanzhong Chen

July 2018

The original article [1] contained minor typesetting errors affecting the following authors: Ziang J...

Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Wong, Gabrielle S
Zhou, Jin
Bin Liu, Jie
Wu, Zhong
Xu, Xinsen
Li, Tianxia
Xu, David
Schumacher, Steven E
Puschhof, Jens
McFarland, James
Zou, Charles
Dulak, Austin
Henderson, Les
Xu, Peng
O'Day, Emily
Rendak, Rachel
Liao, Wei-Li
Cecchi, Fabiola
Hembrough, Todd
Schwartz, Sarit
Szeto, Christopher
Rustgi, Anil K
Wong, Kwok-Kin
Diehl, J Alan
Jensen, Karin
Graziano, Francesco
Ruzzo, Annamaria
Fereshetian, Shaunt
Mertins, Philipp
Carr, Steven A
Beroukhim, Rameen
Nakamura, Kenichi
Oki, Eiji
Watanabe, Masayuki
Baba, Hideo
Imamura, Yu
Catenacci, Daniel
Bass, Adam J

January 2018

In the Supplementary Information originally published with this article, a lane was missing in the β...

Author Correction: The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression (Nature Genetics, (2011), 43, 3, (212-219), 10.1038/ng.767)

Schramek, D. Kotsinas, A. Meixner, A. Wada, T. Elling, U. Pospisilik, J.A. Neely, G.G. Zwick, R.-H. Sigl, V. Forni, G. Serrano, M. Gorgoulis, V.G. Penninger, J.M.

January 2023

Update to: Nature Genetics. Published online 13 February 2011. In the version of this article initia...

Correction to: Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling

Fuqing Hu
Haijie Li
Lu Liu
Feng Xu
Senyan Lai
Xuelai Luo
Junbo Hu
Xi Yang

September 2018

After the publication of this work [1] an error was noticed in Fig. 7e, in which the incorrect infor...

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Iain R. Hutcheson
Janice M. Knowlden
Steve E. Hiscox
Denise Barrow
Julia M. W. Gee
John F. Robertson
Ian O. Ellis
Robert I. Nicholson

August 2018

After the publication of this work [1], an error was noticed in Fig. 2b and Fig. 4b as well as Fig. ...

Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cells

Manabu Emi
Ryungsa Kim
Kazuaki Tanabe
Yoko Uchida
Tetsuya Toge

February 2019

After the publication of this work [1] errors were noticed in Figs. 1a, 6a, and 8a—in which the β-ac...

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.

Xu, Ke
Park, Dongkyoo
Magis, Andrew T
Zhang, Jun
Zhou, Wei
Sica, Gabriel L
Ramalingam, Suresh S
Curran, Walter J
Deng, Xingming

May 2020

An amendment to this paper has been published and can be accessed via the original article

Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study

Hewitt, Lindsay C.
Saito, Yuichi
Wang, Tan
Matsuda, Yoko
Oosting, Jan
Silva, Arnaldo N. S.
Slaney, Hayley L.
Melotte, Veerle
Hutchins, Gordon
Tan, Patrick
Yoshikawa, Takaki
Arai, Tomio
Grabsch, Heike I.

November 2019

In the original publication of this article, Fig.??2 was published incorrectly. The correct Fig.??2 ...

Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.

Xiao, Wenwu
Ma, Weijie
Wei, Sixi
Li, Qianping
Liu, Ruiwu
Carney, Randy P
Yang, Kevin
Lee, Joyce
Nyugen, Alan
Yoneda, Ken Y
Lam, Kit S
Li, Tianhong

July 2019

The original article [1] contains an error in Fig. 2 whereby Fig. 2D has mistakenly been omitted. Fi...

Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers

Šuštić, Tonći
van Wageningen, Sake
Bosdriesz, Evert
Reid, Robert J. D.
Dittmar, John
Lieftink, Cor
Beijersbergen, Roderick L.
Wessels, Lodewyk F. A.
Rothstein, Rodney
Bernards, René

January 2021

An amendment to this paper has been published and can be accessed via the original article

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Borrero-Palacios, A
Cebrián, A
Gómez Del Pulgar, M T
García-Carbonero, R
Garcia-Alfonso, P
Aranda, E
Elez, E
López-López, R
Cervantes, A
Valladares, M
Nadal, C
Viéitez, J M
Guillén-Ponce, C
Rodríguez, J
Hernández, I
García, J L
Vega-Bravo, R
Puime-Otin, A
Martínez-Useros, J
Del Puerto-Nevado, L
Rincón, R
Rodríguez-Remírez, M
Rojo, F
García-Foncillas, J

May 2019

A correction to this article has been published and is linked from the HTML and PDF versions of this...

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

Borrero-Palacios, A.
Cebrián, A.
Gómez del Pulgar, M. T.
García-Carbonero, R.
Garcia-Alfonso, P.
Aranda, E.
Elez, E.
López-López, R.
Cervantes, A.
Valladares, M.
Nadal, C.
Viéitez, J. M.
Guillén-Ponce, C.
Rodríguez, J.
Hernández, I.
García, J. L.
Vega-Bravo, R.
Puime-Otin, A.
Martínez-Useros, J.
Del Puerto-Nevado, L.
Rincón, R.
Rodríguez-Remírez, M.
Rojo, F.
García-Foncillas, J.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)

May 2019

The original version of this Article contained an error in the spelling of the author P. Garcia-Alfo...

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Kang, MH
Jeong, KJ
Kim, WY
Lee, HJ
Gong, G
Suh, N
Győrffy, Balázs
Kim, S
Jeong, SY
Mills, GB
Park, Y-Y

November 2019

The original version of this article contained error in Figure 2e. In Figure 2e, the 6th colony imag...

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

Man-Qing Cao
A-Bin You
Xiao-Dong Zhu
Wei Zhang
Yuan-Yuan Zhang
Shi-Zhe Zhang
Kei-wei Zhang
Hao Cai
Wen-Kai Shi
Xiao-Long Li
Kang-Shuai Li
Dong-Mei Gao
De-Ning Ma
Bo-Gen Ye
Cheng-Hao Wang
Cheng-Dong Qin
Hui-Chan Sun
Ti Zhang
Zhao-You Tang

April 2018

The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing Cy...

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7).

Ebert, K.
Zwingenberger, G.
Barbaria, E.
Keller, S.
Heck, C.
Arnold, R.
Hollerieth, V.
Mattes, J.
Geffers, R.
Raimundez-Alvarez, E.
Hasenauer, J.
Luber, B.

January 2020

Following publication of the original article [1], the authors reported an error in the labeling of ...

Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Xiaolan Lian
Yu-Min Lin
Shingo Kozono
Megan K. Herbert
Xin Li
Xiaohong Yuan
Jiangrui Guo
Yafei Guo
Min Tang
Jia Lin
Yiping Huang
Bixin Wang
Chenxi Qiu
Cheng-Yu Tsai
Jane Xie
Ziang Jeff Gao
Yong Wu
Hekun Liu
Xiao Zhen Zhou
Kun Ping Lu
Yuanzhong Chen

July 2018

The original article [1] contained minor typesetting errors affecting the following authors: Ziang J...

Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Wong, Gabrielle S
Zhou, Jin
Bin Liu, Jie
Wu, Zhong
Xu, Xinsen
Li, Tianxia
Xu, David
Schumacher, Steven E
Puschhof, Jens
McFarland, James
Zou, Charles
Dulak, Austin
Henderson, Les
Xu, Peng
O'Day, Emily
Rendak, Rachel
Liao, Wei-Li
Cecchi, Fabiola
Hembrough, Todd
Schwartz, Sarit
Szeto, Christopher
Rustgi, Anil K
Wong, Kwok-Kin
Diehl, J Alan
Jensen, Karin
Graziano, Francesco
Ruzzo, Annamaria
Fereshetian, Shaunt
Mertins, Philipp
Carr, Steven A
Beroukhim, Rameen
Nakamura, Kenichi
Oki, Eiji
Watanabe, Masayuki
Baba, Hideo
Imamura, Yu
Catenacci, Daniel
Bass, Adam J

January 2018

In the Supplementary Information originally published with this article, a lane was missing in the β...

Author Correction: The stress kinase MKK7 couples oncogenic stress to p53 stability and tumor suppression (Nature Genetics, (2011), 43, 3, (212-219), 10.1038/ng.767)

Schramek, D. Kotsinas, A. Meixner, A. Wada, T. Elling, U. Pospisilik, J.A. Neely, G.G. Zwick, R.-H. Sigl, V. Forni, G. Serrano, M. Gorgoulis, V.G. Penninger, J.M.

January 2023

Update to: Nature Genetics. Published online 13 February 2011. In the version of this article initia...

Correction to: Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling

Fuqing Hu
Haijie Li
Lu Liu
Feng Xu
Senyan Lai
Xuelai Luo
Junbo Hu
Xi Yang

September 2018

After the publication of this work [1] an error was noticed in Fig. 7e, in which the incorrect infor...

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells

Iain R. Hutcheson
Janice M. Knowlden
Steve E. Hiscox
Denise Barrow
Julia M. W. Gee
John F. Robertson
Ian O. Ellis
Robert I. Nicholson

August 2018

After the publication of this work [1], an error was noticed in Fig. 2b and Fig. 4b as well as Fig. ...

Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cells

Manabu Emi
Ryungsa Kim
Kazuaki Tanabe
Yoko Uchida
Tetsuya Toge

February 2019

After the publication of this work [1] errors were noticed in Figs. 1a, 6a, and 8a—in which the β-ac...

Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.

Xu, Ke
Park, Dongkyoo
Magis, Andrew T
Zhang, Jun
Zhou, Wei
Sica, Gabriel L
Ramalingam, Suresh S
Curran, Walter J
Deng, Xingming

May 2020

An amendment to this paper has been published and can be accessed via the original article

Correction to: KRAS status is related to histological phenotype in gastric cancer: results from a large multicentre study

Hewitt, Lindsay C.
Saito, Yuichi
Wang, Tan
Matsuda, Yoko
Oosting, Jan
Silva, Arnaldo N. S.
Slaney, Hayley L.
Melotte, Veerle
Hutchins, Gordon
Tan, Patrick
Yoshikawa, Takaki
Arai, Tomio
Grabsch, Heike I.

November 2019

In the original publication of this article, Fig.??2 was published incorrectly. The correct Fig.??2 ...

Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.

Xiao, Wenwu
Ma, Weijie
Wei, Sixi
Li, Qianping
Liu, Ruiwu
Carney, Randy P
Yang, Kevin
Lee, Joyce
Nyugen, Alan
Yoneda, Ken Y
Lam, Kit S
Li, Tianhong

July 2019

The original article [1] contains an error in Fig. 2 whereby Fig. 2D has mistakenly been omitted. Fi...

Correction to: A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers

Šuštić, Tonći
van Wageningen, Sake
Bosdriesz, Evert
Reid, Robert J. D.
Dittmar, John
Lieftink, Cor
Beijersbergen, Roderick L.
Wessels, Lodewyk F. A.
Rothstein, Rodney
Bernards, René

January 2021

An amendment to this paper has been published and can be accessed via the original article

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer.

Borrero-Palacios, A
Cebrián, A
Gómez Del Pulgar, M T
García-Carbonero, R
Garcia-Alfonso, P
Aranda, E
Elez, E
López-López, R
Cervantes, A
Valladares, M
Nadal, C
Viéitez, J M
Guillén-Ponce, C
Rodríguez, J
Hernández, I
García, J L
Vega-Bravo, R
Puime-Otin, A
Martínez-Useros, J
Del Puerto-Nevado, L
Rincón, R
Rodríguez-Remírez, M
Rojo, F
García-Foncillas, J

May 2019

A correction to this article has been published and is linked from the HTML and PDF versions of this...

Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

Borrero-Palacios, A.
Cebrián, A.
Gómez del Pulgar, M. T.
García-Carbonero, R.
Garcia-Alfonso, P.
Aranda, E.
Elez, E.
López-López, R.
Cervantes, A.
Valladares, M.
Nadal, C.
Viéitez, J. M.
Guillén-Ponce, C.
Rodríguez, J.
Hernández, I.
García, J. L.
Vega-Bravo, R.
Puime-Otin, A.
Martínez-Useros, J.
Del Puerto-Nevado, L.
Rincón, R.
Rodríguez-Remírez, M.
Rojo, F.
García-Foncillas, J.
Instituto de Investigación Sanitaria Fundación Jiménez Díaz (ISS-FJD)

May 2019

The original version of this Article contained an error in the spelling of the author P. Garcia-Alfo...

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Kang, MH
Jeong, KJ
Kim, WY
Lee, HJ
Gong, G
Suh, N
Győrffy, Balázs
Kim, S
Jeong, SY
Mills, GB
Park, Y-Y

November 2019

The original version of this article contained error in Figure 2e. In Figure 2e, the 6th colony imag...

Correction to: miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

Man-Qing Cao
A-Bin You
Xiao-Dong Zhu
Wei Zhang
Yuan-Yuan Zhang
Shi-Zhe Zhang
Kei-wei Zhang
Hao Cai
Wen-Kai Shi
Xiao-Long Li
Kang-Shuai Li
Dong-Mei Gao
De-Ning Ma
Bo-Gen Ye
Cheng-Hao Wang
Cheng-Dong Qin
Hui-Chan Sun
Ti Zhang
Zhao-You Tang

April 2018

The original article [1] contains an error in Fig. 5a whereby the Western blot bands representing Cy...

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines (BMC Cancer, (2020), 20, 1, (1039), 10.1186/s12885-020-07540-7).

Ebert, K.
Zwingenberger, G.
Barbaria, E.
Keller, S.
Heck, C.
Arnold, R.
Hollerieth, V.
Mattes, J.
Geffers, R.
Raimundez-Alvarez, E.
Hasenauer, J.
Luber, B.

January 2020

Following publication of the original article [1], the authors reported an error in the labeling of ...

Correction to: Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways

Xiaolan Lian
Yu-Min Lin
Shingo Kozono
Megan K. Herbert
Xin Li
Xiaohong Yuan
Jiangrui Guo
Yafei Guo
Min Tang
Jia Lin
Yiping Huang
Bixin Wang
Chenxi Qiu
Cheng-Yu Tsai
Jane Xie
Ziang Jeff Gao
Yong Wu
Hekun Liu
Xiao Zhen Zhou
Kun Ping Lu
Yuanzhong Chen

July 2018

The original article [1] contained minor typesetting errors affecting the following authors: Ziang J...

Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Abstract

Extracted data

Topics

Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

Abstract

Extracted data

Topics

Related items

Related items